Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/32901
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2022-01-01
Colecciones
- IOC - Artigos de Periódicos [12514]
Metadatos
Mostrar el registro completo del ítem
GLUCOCORTICOIDS DECREASE THE NUMBERS AND ACTIVATION OFMAST CELLS BY INDUCING THE TRANSACTIVATION RECEPTORS OF AGES
Autor
Afiliación
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil / Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação. Rio de Janeiro, RJ, Basil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ. Brasil / Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação. Rio de Janeiro, RJ, Basil.
Resumen en ingles
Glucocorticoids (GCs) are potent anti-allergic compounds that function, at least in part, by inhibiting
signaling pathways in mast cells. We hypothesized that the GC-induced mastocytopenia
and suppression of mast cell activation are mediated by the advanced glycation end products
(AGEs)/receptors of AGEs (RAGEs) signaling axis.We evaluated the role of AGEs in GC-mediated
mastocytopenia and impaired mast cell degranulation in male Wistar rats and Swiss–Webster
mice subcutaneously injected with dexamethasone or prednisolone (0.1 mg/kg) once a day for
21 consecutive days. The animals were treated with either the AGE inhibitor aminoguanidine
(250 mg/kg), the RAGE antagonist FPS-ZM1 (1 mg/kg) or the galectin-3 antagonist GSC-100
(1 mg/kg) daily for 18 days, starting 3 days following GC treatment. Aminoguanidine inhibited
GC-induced mast cell apoptosis and restored mast cell numbers in the pleural cavity of GC-treated
rats. Aminoguanidine also reversed the GC-induced reduction in histamine release triggered by
allergens or compound 48/80 in vitro. GC treatment induced RAGE and galectin expression in
mast cells, and blocking these agents by FPS-ZM1 or GSC-100 significantly reversed mast cell
numbers in the peritoneal cavity and mesenteric tissue of GC-treated mice. In addition, the
combination of GC and AGE-induced mast cell apoptosis in vitro was inhibited by both FPS-ZM1
and GSC-100. We concluded that the GC-induced mastocytopenia and suppression of mast cell
stimulation are associated with the gene transactivation of RAGE and galectin-3.
Compartir